Lulimac 50 Gel contains Luliconazole 1% w/w, a topical antifungal agent indicated for the treatment of various superficial fungal infections of the skin. Luliconazole belongs to the imidazole class of antifungals and exhibits broad-spectrum activity against dermatophytes, yeasts, and molds by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes. This disruption leads to increased membrane permeability and ultimately fungal cell death. Lulimac 50 Gel is primarily prescribed for conditions such as tinea corporis, tinea cruris, and tinea pedis, providing effective relief from symptoms including itching, redness, scaling, and inflammation. The gel formulation allows for easy application and rapid absorption into the affected area, enhancing patient compliance and therapeutic outcomes. Treatment duration typically ranges from one to two weeks, depending on the severity and type of infection, and it is important to continue use for the full prescribed period to prevent recurrence. Lulimac 50 Gel is generally well tolerated, with minimal local adverse effects such as mild burning or irritation. It is contraindicated in patients with known hypersensitivity to luliconazole or any component of the formulation. As a topical agent, systemic absorption is negligible, reducing the risk of systemic side effects.